102 related articles for article (PubMed ID: 15446564)
1. [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].
Chohnabayashi N; Uchiyama N; Nishimura N; Nasu H
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1395-8. PubMed ID: 15446564
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
Gebbia V; Galetta D; Lorusso V; Caruso M; Verderame F; Pezzella G; Borsellino N; Durini E; Valenza R; Agostara B; Colucci G;
Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
[TBL] [Abstract][Full Text] [Related]
3. First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
Bernardo G; Cuzzoni Q; Strada MR; Bernardo A; Brunetti G; Jedrychowska I; Pozzi U; Palumbo R
Cancer Invest; 2002; 20(3):293-302. PubMed ID: 12025223
[TBL] [Abstract][Full Text] [Related]
4. Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Ramsey SD; Moinpour CM; Lovato LC; Crowley JJ; Grevstad P; Presant CA; Rivkin SE; Kelly K; Gandara DR
J Natl Cancer Inst; 2002 Feb; 94(4):291-7. PubMed ID: 11854391
[TBL] [Abstract][Full Text] [Related]
5. First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V; Lorusso V; Galetta D; Caruso M M; Palomba G; Riccardi F; Borsellino N; Carrozza F; Leo S; Ferraù F; Cinieri S; Mancuso G; Mancarella S; Colucci G
Lung Cancer; 2010 Aug; 69(2):218-24. PubMed ID: 19910076
[TBL] [Abstract][Full Text] [Related]
6. Re: Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Malayeri R
J Natl Cancer Inst; 2002 Aug; 94(15):1172; author reply 1172. PubMed ID: 12165643
[No Abstract] [Full Text] [Related]
7. Hybrid (intravenous and oral) administration of vinorelbine plus cisplatinum followed by oral vinorelbine as first-line therapy of advanced non-small cell lung cancer: a phase II study.
Martoni AA; Melotti B; Sperandi F; Giaquinta S; Piana E; Pavesi L; Da Prada G; Lelli G
Lung Cancer; 2008 Jun; 60(3):387-92. PubMed ID: 18160123
[TBL] [Abstract][Full Text] [Related]
8. [Lung carcinoma].
Sutani A; Kobayashi K
Gan To Kagaku Ryoho; 2006 May; 33(5):590-4. PubMed ID: 16685153
[TBL] [Abstract][Full Text] [Related]
9. [A case of recurrent lung cancer successfully treated with vinorelbine and cisplatin/carboplatin].
Suzuki H; Shirane K; Nasu H; Muto O; Nakagawa T; Ogawa J
Gan To Kagaku Ryoho; 2003 Jul; 30(7):981-4. PubMed ID: 12894714
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Kelly K; Crowley J; Bunn PA; Presant CA; Grevstad PK; Moinpour CM; Ramsey SD; Wozniak AJ; Weiss GR; Moore DF; Israel VK; Livingston RB; Gandara DR
J Clin Oncol; 2001 Jul; 19(13):3210-8. PubMed ID: 11432888
[TBL] [Abstract][Full Text] [Related]
11. [Two cases of recurrent non-small cell lung cancer successfully treated with S-1 as fifth-line chemotherapy].
Takakuwa O; Oguri T; Sato S; Nakao M; Ohta C; Iwashima Y; Miyazaki M; Maeno K; Kutsuna T; Nakamura A; Ueda R
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1721-4. PubMed ID: 19838034
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
Belani C;
Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
[TBL] [Abstract][Full Text] [Related]
14. [Successful chemotherapy with carboplatin and docetaxel for an elderly patient with advanced non-small cell lung cancer].
Kawashima S; Kawashima T; Kuroda T; Kikkawa K; Nishi Y; Tanabe M; Gotou T; Matsuzawa Y; Shirai K
Gan To Kagaku Ryoho; 2006 Apr; 33(4):493-5. PubMed ID: 16612159
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
16. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
[TBL] [Abstract][Full Text] [Related]
17. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
18. [A case of non-small-cell lung cancer successfully treated using combination chemotherapy with CDDP and vinorelbine].
Shimizu K; Watanabe E; Hamanaka S; Onuma S; Nakano M; Yamazaki T; Higa M; Yamamuro W; Kiguchi E
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1565-8. PubMed ID: 11016002
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
Ou W; Sun HB; Ye X; Zhang BB; Yang H; Fang Q; Li P; Wang SY
J Thorac Oncol; 2010 Jul; 5(7):1033-41. PubMed ID: 20502361
[TBL] [Abstract][Full Text] [Related]
20. [Lung adenocarcinoma with multiple pulmonary metastases completely responsive to combination chemotherapy with carboplatin and weekly paclitaxel--a case report].
Ishida T; Tomiyasu M; Kohso H; Iwanami T; Ikegami T; Okazaki J; Emi Y; Kido A; Ezaki T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1313-6. PubMed ID: 14518412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
